title: Histological and Immunohistological Findings Using Anti-Cortisol Antibody in Atopic Dermatitis with Topical Steroid Addiction.
abstract: BACKGROUND
  Though topical steroid addiction (TSA) in patients with atopic dermatitis (AD) has been recently discussed as a clinical problem, there are very few studies about its mechanism. The purpose of this study was to elucidate histological and immunohistological characteristics of TSA using anti-cortisol antibody.
  
  
  METHODS
  Skin biopsy specimen from eight patients with AD was stained by anti-cortisol antibody (Biorbyt, orb79379). Subjects consisted of a child patient with a short history of topical corticosteroids (TCS) application, an adult patient with a long history of TCS application, and six adult patients who have experienced topical steroid withdrawal (TSW) and the rebound phenomenon.
  
  
  RESULTS
  The staining in the epidermis by anti-cortisol antibody presented patchy defects in the child patient, the patient with a long history of TCS application, and two patients at the rebound period. Parakeratosis with poor formation of corneal layer was obvious in the child patient, the patient with a long history of TCS application, two patients recovered from TSA, and two patients at the rebound period.
  
  
  CONCLUSIONS
  Prolonged application of TCS might suppress the cortisol production of keratinocytes which is poorly developed at the early ages before childhood and completed naturally as to growth. Rebound phenomenon after TSW can occur due to the relative insufficiency of cortisol in the epidermis and the immature corneal layer formation.
authors.affiliation: Tsurumai Kouen Clinic, Nagoya, Japan. moto@earth.ocn.ne.jp.
authors.forename: Mototsugu
authors.initials: M
authors.lastname: Fukaya
keywords: Atopic dermatitis; Cortisol; Topical steroid addiction
references.citation: Dermatol Surg. 1999 Oct;25(10):781-4; discussion 785
references.pmid: 10594579
references.citation: J Am Acad Dermatol. 2015 Mar;72(3):541-549.e2
references.pmid: 25592622
references.citation: Drug Healthc Patient Saf. 2014 Oct 14;6:131-8
references.pmid: 25378953
references.citation: J Dermatol. 1991 Aug;18(8):454-64
references.pmid: 1761793
references.citation: J Cell Biochem. 2011 Jun;112(6):1499-505
references.pmid: 21344493
references.citation: J Formos Med Assoc. 1991 Jul;90(7):664-9
references.pmid: 1681017
references.citation: Lancet. 1951 Dec 8;2(6693):1061-4
references.pmid: 14881557
references.citation: J Invest Dermatol. 1984 Apr;82(4):345-52
references.pmid: 6368701
references.citation: J Steroid Biochem Mol Biol. 2013 Sep;137:107-23
references.pmid: 23435015
references.citation: Int J Dermatol. 1979 Jan-Feb;18(1):23-31
references.pmid: 153891
references.citation: Exp Dermatol. 2013 Oct;22(10):662-4
references.pmid: 24079737